BridgeMD
New treatment option for Stroke
Official title Language Processing and TMS
ClinicalTrials.gov ID: NCT05425615
What this study is testing
- What it's testing
- This study will examine the effect of TMS on people with stroke and aphasia as well as healthy individuals.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 85. Healthy volunteers may be eligible.
You may be able to join if
- Diagnosed with left hemisphere stroke
- Consent date \>= 1 month after stroke onset
- Right-handed
- Fluent in English
- 18 years of age or older
You likely can't join if
- Severe cognitive, auditory or visual impairments that would preclude cognitive and language testing
- Non-decisional per decisionality questionnaire or other clinical assessment
- Presence of major untreated or unstable psychiatric disease (e.g. schizophrenia, bipolar disease)
- A chronic medical condition that is not treated or is unstable
- Presence of
- cardiac stimulators or pacemakers or intracardiac lines
See the full eligibility criteria
- Diagnosed with left hemisphere stroke
- Consent date \>= 1 month after stroke onset
- Right-handed
- Fluent in English
- 18 years of age or older
- Severe cognitive, auditory or visual impairments that would preclude cognitive and language testing
- Non-decisional per decisionality questionnaire or other clinical assessment
- Presence of major untreated or unstable psychiatric disease (e.g. schizophrenia, bipolar disease)
- A chronic medical condition that is not treated or is unstable
- Presence of
- cardiac stimulators or pacemakers or intracardiac lines
- neurostimulators
- medication infusion device
- any other implants near the scalp (e.g., cochlear implants) or in the eye
- metal in the body
- Pregnancy
- History of skull fractures, or skin diseases
- History of ongoing or unmanaged seizures or a family history of epilepsy
- Presence of factors that potentially decrease seizure thresholds
- On pro-convulsant medications
- Untreated Sleep deprivation or insomnia
- Ongoing alcoholism or illegal drug abuse (e.g., cocaine or MDMA users)
- History of dyslexia or other developmental learning disabilities
The study team makes the final eligibility decision.
Where it's taking place
- Milwaukee, Wisconsin, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 85 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Milwaukee, Wisconsin, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.